Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The induction of regulatory T cell (Treg) formation refers to the biological processes and molecular pathways that drive the differentiation of naïve CD4+ T cells into regulatory T cells. These specialized immune cells play a critical role in maintaining immune tolerance, preventing autoimmunity, and modulating immune responses. Key factors include Foxp3, IL-2, and TGF-β. Induction can occur in the thymus (tTreg) or periphery (pTreg/iTreg), influenced by antigen receptor signaling, co-stimulatory molecules, and cytokines. Resultant Tregs suppress immune responses through various mechanisms, including cytokine secretion and contact-dependent inhibition.
N/A
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Induction of Regulatory T Cell Formation.